TY  - GEN
AU  - Alvarez,Ricardo H
AU  - Booser,Daniel J
AU  - Cristofanilli,Massimo
AU  - Sahin,Aysegul A
AU  - Strom,Eric A
AU  - Guerra,Laura
AU  - Kau,Shu-Wan
AU  - Gonzalez-Angulo,Ana M
AU  - Hortobagyi,Gabriel N
AU  - Valero,Vicente
TI  - Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : long-term results from the University of Texas M. D. Anderson Cancer Center Study ID97-099
SN  - 0008-543X
PY  - 2010///0319
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Chemotherapy, Adjuvant
KW  - Combined Modality Therapy
KW  - Cyclophosphamide
KW  - Disease-Free Survival
KW  - Docetaxel
KW  - Doxorubicin
KW  - administration & dosage
KW  - Drug Administration Schedule
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Methotrexate
KW  - Middle Aged
KW  - Radiotherapy, Adjuvant
KW  - Taxoids
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/cncr.24901
ER  -